Finance

CHINA XLX FERT(01866.HK): 2026 Q1 Report - Profit Attributable to Shareholders stood at CNY 299.64 million, YoY increase of 51.7% - NewTimeSpace
CHINA XLX FERT(01866.HK): 2026 Q1 Report - Profit Attributable to Shareholders stood at CNY 299.64 million, YoY increase of 51.7%

NewTimeSpace News: May 15, 2026, CHINA XLX FERT(01866.HK) released its Q1 Report for the period ended December 31, 2026, Total Revenue stood at CNY 6.82 billion, increased by 16.71% YoY

NewTimeSpace · 2026-05-18
CHINA XLX FERT01866.HKprofit
INFINITY DEV(00640.HK): FY 25/26 Interim Report - Profit Attributable to Shareholders stood at HKD 48.81 million, YoY decrease of 13.79% - NewTimeSpace
INFINITY DEV(00640.HK): FY 25/26 Interim Report - Profit Attributable to Shareholders stood at HKD 48.81 million, YoY decrease of 13.79%

NewTimeSpace News: May 15, 2026, INFINITY DEV(00640.HK) released its Interim Report for the period ended September 30, 2026, Total Revenue stood at HKD 401.54 million, decreased by 1.9% YoY

NewTimeSpace · 2026-05-18
INFINITY DEV00640.HKfinancials
QINGDA ORIENTAL(08115.HK): 2026 Q1 Report - Profit Attributable to Shareholders stood at CNY 7.27 million, YoY increase of 627.33% - NewTimeSpace
QINGDA ORIENTAL(08115.HK): 2026 Q1 Report - Profit Attributable to Shareholders stood at CNY 7.27 million, YoY increase of 627.33%

NewTimeSpace News: May 15, 2026, QINGDA ORIENTAL(08115.HK) released its Q1 Report for the period ended December 31, 2026, Total Revenue stood at CNY 62.45 million, increased by 220.94% YoY

NewTimeSpace · 2026-05-18
QINGDA ORIENTAL08115.HKprofit growth
ZHUGUANG HOLD(01176.HK): 2025 Annual Report - Profit Attributable to Shareholders stood at loss of HKD 6.19 billion, loss widened by 81.33% YoY - NewTimeSpace
ZHUGUANG HOLD(01176.HK): 2025 Annual Report - Profit Attributable to Shareholders stood at loss of HKD 6.19 billion, loss widened by 81.33% YoY

NewTimeSpace News: May 15, 2026, ZHUGUANG HOLD(01176.HK) released its Annual Report for the period ended December 31, 2025, Total Revenue stood at HKD 1.39 billion, decreased by 12.3% YoY

NewTimeSpace · 2026-05-18
ZHUGUANG HOLD01176.HKLoss widens
Yidu Tech (02158.HK) Wins Full-hospital Data Center & Informatization Project in Fuling Chongqing, Worth Approximately RMB 9.65 Million - NewTimeSpace
Yidu Tech (02158.HK) Wins Full-hospital Data Center & Informatization Project in Fuling Chongqing, Worth Approximately RMB 9.65 Million

NewTimeSpace News: Yidu Tech Inc. (02158.HK) announced that its affiliate Yidu Cloud (Beijing) Technology Co., Ltd. has won the bid for the full-hospital data center and informatization project of Fuling Hospital Affiliated to Chongqing University, issued by Chongqing Digital Fuling Big Data Industry Development Co., Ltd., with a total project value of approximately RMB 9.6495 million.

NewTimeSpace · 2026-05-18
YIDU TECH02158.HKwin the bid
HBM HOLDINGS-B (02142.HK): Preclinical Data Unveiled for First AI-Derived Candidate LET003, Showing Remarkable Fat Loss & Muscle Preservation Combined with Semaglutide - NewTimeSpace
HBM HOLDINGS-B (02142.HK): Preclinical Data Unveiled for First AI-Derived Candidate LET003, Showing Remarkable Fat Loss & Muscle Preservation Combined with Semaglutide

NewTimeSpace News: Hbm Holdings Limited (02142.HK) announced preclinical research findings of LET003, its next-generation ACVR2A/2B-targeted monoclonal antibody developed via the Hu-mAtrIx™ AI platform. Data revealed that combination therapy of LET003 and semaglutide delivers markedly enhanced fat reduction and effective lean mass preservation. The combined group achieved a 34.7% greater reduction in fat mass and a 5.7% rise in lean mass compared with semaglutide monotherapy.

NewTimeSpace · 2026-05-18
HBM HOLDINGS-B02142.HKpreclinical data
TRANSTHERA-B (02617.HK): Clinical Data of Core Product Tiengrtinib Published in Nature Communications - NewTimeSpace
TRANSTHERA-B (02617.HK): Clinical Data of Core Product Tiengrtinib Published in Nature Communications

NewTimeSpace News: TransThera Sciences (Nanjing), Inc. (02617.HK) announced that exploratory clinical findings of its core product tiengrtinib as monotherapy and in combination with atezolizumab for advanced solid tumors have been published in Nature Communications (Impact Factor=15.7). Clinical data show that the objective response rate (ORR) of tiengrtinib monotherapy reached 16.7%, while the combination regimen achieved an ORR of 22.6%. It demonstrated prominent efficacy in cholangiocarcinoma patients, with an ORR of 30.8% under monotherapy.

NewTimeSpace · 2026-05-17
TRANSTHERA-B02617.HKclinical development
FAMEGLOW(08603.HK): FY 25/26 Annual Report - Profit Attributable to Shareholders stood at HKD 54.64 million, YoY increase of 19.49% - NewTimeSpace
FAMEGLOW(08603.HK): FY 25/26 Annual Report - Profit Attributable to Shareholders stood at HKD 54.64 million, YoY increase of 19.49%

NewTimeSpace News: May 15, 2026, FAMEGLOW(08603.HK) released its Annual Report for the period ended March 31, 2026, Total Revenue stood at HKD 589.79 million, increased by 35.5% YoY

NewTimeSpace · 2026-05-17
FAMEGLOW08603.HKprofit growth
SUNLIGHT HLDGS(08451.HK): FY 25/26 Interim Report - Profit Attributable to Shareholders stood at SGD 468 thousand, YoY increase of 170.52% - NewTimeSpace
SUNLIGHT HLDGS(08451.HK): FY 25/26 Interim Report - Profit Attributable to Shareholders stood at SGD 468 thousand, YoY increase of 170.52%

NewTimeSpace News: May 15, 2026, SUNLIGHT HLDGS(08451.HK) released its Interim Report for the period ended September 30, 2026, Total Revenue stood at SGD 7.05 million, increased by 3.12% YoY

NewTimeSpace · 2026-05-17
SUNLIGHT HLDGS08451.HKfinancials
CHINA RAILWAY(00390.HK) will spend CNY 80 million to repurchase 15.97 million shares on May 15, 2026 - NewTimeSpace
CHINA RAILWAY(00390.HK) will spend CNY 80 million to repurchase 15.97 million shares on May 15, 2026

NewTimeSpace News: CHINA RAILWAY(00390.HK) will spend CNY 80 million to repurchase 15.97 million shares on May 15, 2026.

NewTimeSpace · 2026-05-15
CHINA RAILWAY00390.HKShare Repurchase
HWORLD-S(01179.HK): 2026 Q1 Report - Profit Attributable to Shareholders stood at CNY 817 million, YoY decrease of 8.61% - NewTimeSpace
HWORLD-S(01179.HK): 2026 Q1 Report - Profit Attributable to Shareholders stood at CNY 817 million, YoY decrease of 8.61%

NewTimeSpace News: May 15, 2026, HWORLD-S(01179.HK) released its Q1 Report for the period ended December 31, 2026, Total Revenue stood at CNY 6 billion, increased by 11.14% YoY

NewTimeSpace · 2026-05-15
HWORLD-S01179.HKfinancials
JX ENERGY(03395.HK): 2026 Q1 Report - Profit Attributable to Shareholders stood at loss of CAD 523.33 thousand, loss narrowed by 85.37% YoY - NewTimeSpace
JX ENERGY(03395.HK): 2026 Q1 Report - Profit Attributable to Shareholders stood at loss of CAD 523.33 thousand, loss narrowed by 85.37% YoY

NewTimeSpace News: May 15, 2026, JX ENERGY(03395.HK) released its Q1 Report for the period ended December 31, 2026, Total Revenue stood at CAD 2.89 million, increased by 6.33% YoY

NewTimeSpace · 2026-05-15
JX ENERGY03395.HKloss narrowed
SHOUCHENG(00697.HK): 2026 Q1 Report - Profit Attributable to Shareholders stood at HKD 78.53 million, YoY decrease of 63.11% - NewTimeSpace
SHOUCHENG(00697.HK): 2026 Q1 Report - Profit Attributable to Shareholders stood at HKD 78.53 million, YoY decrease of 63.11%

NewTimeSpace News: May 15, 2026, SHOUCHENG(00697.HK) released its Q1 Report for the period ended December 31, 2026, Total Revenue stood at HKD 327.11 million, decreased by 7.11% YoY

NewTimeSpace · 2026-05-15
SHOUCHENG00697.HKQ1 Report
LEAPMOTOR(09863.HK): 2026 Q1 Report - Profit Attributable to Shareholders stood at loss of CNY 390 million, loss widened by 200% YoY - NewTimeSpace
LEAPMOTOR(09863.HK): 2026 Q1 Report - Profit Attributable to Shareholders stood at loss of CNY 390 million, loss widened by 200% YoY

NewTimeSpace News: May 15, 2026, LEAPMOTOR(09863.HK) released its Q1 Report for the period ended December 31, 2026, Total Revenue stood at CNY 10.82 billion, increased by 7.98% YoY

NewTimeSpace · 2026-05-15
Leapmotor09863.HKLoss widens
ALI HEALTH(00241.HK): FY 25/26 Annual Report - Profit Attributable to Shareholders stood at CNY 1.94 billion, YoY increase of 35.17% - NewTimeSpace
ALI HEALTH(00241.HK): FY 25/26 Annual Report - Profit Attributable to Shareholders stood at CNY 1.94 billion, YoY increase of 35.17%

NewTimeSpace News: May 14, 2026, ALI HEALTH(00241.HK) released its Annual Report for the period ended March 31, 2026, Total Revenue stood at CNY 34.26 billion, increased by 11.95% YoY

NewTimeSpace · 2026-05-15
ALI HEALTH00241.HKprofit growth
CHINAGOLDINTL(02099.HK): 2026 Q1 Report - Profit Attributable to Shareholders stood at USD 233.96 million, YoY increase of 175.2% - NewTimeSpace
CHINAGOLDINTL(02099.HK): 2026 Q1 Report - Profit Attributable to Shareholders stood at USD 233.96 million, YoY increase of 175.2%

NewTimeSpace News: May 15, 2026, CHINAGOLDINTL(02099.HK) released its Q1 Report for the period ended December 31, 2026, Total Revenue stood at USD 453.2 million, increased by 65.95% YoY

NewTimeSpace · 2026-05-15
CHINAGOLDINTL02099.HKprofit
Previous1..9798 99100101..152     152 pages total